Skip to main content
. 2022 Jul 7;27:100521. doi: 10.1016/j.lanwpc.2022.100521

Table 6.

Health and economic impact of AMR in Australia: worst- and best-case scenarios.

Organism Worst case-high AMR prevalence, (95%CI) Best case- low AMR prevalence, (95%CI)
3GCR E. coli BSI Resistance, %
number of isolates
19.8% (16.96, 22.64)
n = 197
6% (4.32, 7.68)
n = 201
Number of infections 1345 (747, 2162) 410 (213, 682)
Extra deaths 184 (12, 789) 55 (4, 250)
Extra hospital days 3147 (1739, 5065) 959 (498, 1600)
Hospital cost, AUD $5,982,267
($3305674, $9628303)
$1,823,382
(947288, $3042011)
3GCR E. coli UTI Resistance, %
number of isolates
13.3% (12.74, 13.86)
n = 3680
5.1% (4.94, 5.26)
n = 19169
Number of infections 13,743 (7673, 21503) 5285 (2984, 8215)
Extra deaths 0 0
Extra hospital days 13,876 (7656, 21957) 5338 (2955, 8513)
Hospital costs, AUD $26,378,997
($14553831, $41741105)
$10,147,651
($5617252, $16183897)
3GCR
K. pneumoniae BSI
Resistance, %
number of isolates
27% (19.70, 34.29)
n = 37
3.7% (2.32, 5.07)
n = 189
Number of infections 1105 (566, 1837) 152 (74, 264)
Extra deaths 139 (36, 711) 19 (0, 96)
Extra hospital days 8034 (4127, 13312) 1102 (536, 1921)
Hospital costs, AUD $15,271,828 ($7846376, $25307002) $2, 095,755 ($1018087, $3652213)
3GCR
K. pneumoniae UTI
Resistance, %
number of isolates
8% (6.55, 9.45)
n = 351
3.2% (2.76, 3.63)
n = 1640
Number of infections 2240 (1225, 3617) 897 (494, 1429)
Extra deaths 0 (0, 371) 0
Extra hospital days 5129 (2797, 8312) 2053 (1121, 3309)
Hospital costs, AUD $9,750,931
($5316376, $15801525)
$3,902,408
($2,130,416, $6290122)
MRSA BSI Resistance, %
number of isolates
48.8% (43.28, 54.32)
n = 82
5.5% (3.48, 7.52)
n = 127
Number of infections 5,614 (3140, 8857) 639 (311, 1111)
Extra deaths 788 (257, 1728) 88 (27, 127)
Extra hospital days 44,682 (24954, 70386) 5084 (2467, 8836)
Hospital costs, AUD $89,941,290
($47437029, $133804486)
$9,663,943
($4689142, $16796712)
MRSA UTI Resistance, %
number of isolates
24.5% (23.33, 25.67)
n = 1356
8.3% (5.64, 10.95)
n = 108
Number of infections 1407 (795, 2209) 479 (246, 814)
Extra deaths 44 (0, 179) 15 (0, 61)
Extra hospital days 2024 (1126, 3208) 690 (347, 1178)
Hospital costs, AUD $3,847,292
($2139660, $6099113)
$1,310,820
($659749, $2240290)
Ceftazidime-resistant
P. aeruginosa BSI
Resistance, %
number of isolates
12.1%(8.82, 15.38)
n = 99
1.0% (0.99, 1.99)
n = 101
Number of infections 396 (206, 660) 33 (7, 81)
Extra deaths 82 (4, 273) 7 (0,27)
Extra hospital days 1998 (1039, 3331) 166 (38, 409)
Hospital costs, AUD $3,798,926 ($1975683, $6333053) $315,634
($71535, $778090)
Ceftazidime-resistant
P. aeruginosa RTI
Resistance, %
number of isolates
23.9%(22.49, 25.31)
n = 920
8.1% (7.43, 8.75)
n = 1776
Number of infections 9,719 (5482, 15150) 3302 (1854, 5232)
Extra deaths 1149 (491, 2186) 389 (167, 743)
Extra hospital days 14,663 (8221, 23204) 4982 (2796, 7986)
Hospital costs, AUD $27,873,439
($15627912, $44111126)
$9,470,446
($5315503, $3523878)
Ceftazidime-resistant
P. aeruginosa UTI
Resistance, %
number of isolates
12.3% (10.35, 14.24)
n = 285
2.3% (1.44, 3.16)
n = 306
Number of infections 2773 (1512, 4386) 517 (252, 904)
Extra deaths 51 (0, 169) 10 (0,33)
Extra hospital days 5656 (3057, 9008) 1056 (511, 1854)
Hospital costs, AUD $10,752,971
($5811202, $17123842)
$2,007,363
($970642, $3523878)
VRE BSI Resistance, %
number of isolates
64.2% (59.88, 68.52)
n = 123
7.9% (3.52, 12.28)
n = 38
Number of infections 798 (449, 1234) 98 (41, 188)
Extra deaths 144 (44, 307) 18 (5, 43)
Extra hospital days 1628 (891, 2584) 199 (82, 389)
Hospital costs, AUD $3,095,643
($1694607, $4913053)
$378,840
($156109, $739661)
VRE UTI Resistance, %
number of isolates
57.3% (53.44, 61.16)
n = 164
6.4% (4.61, 8.19)
n = 187
Number of infections 4795 (2678, 7463) 537 (283, 892)
Extra deaths 71 (0, 264) 18(0, 32)
Extra hospital days 6858 (3776, 10778) 767 (399, 1293)
Hospital costs, AUD $13,037,690
($7178984, $20489747)
$1,458,521
($758872, $2457402)